What Does The Historic And Forecasted Market Size Indicate About The Renal Biomarkers Market?
The renal biomarkers market size has grown notably in recent years. It is projected to increase from $1.28 billion in 2024 to $1.38 billion in 2025, achieving a compound annual growth rate (CAGR) of 7.8%. The historic growth can be credited to an amplified occurrence of kidney illnesses, advancements in medical diagnostics, an aging population, heightened awareness of early disease detection, and a rise in chronic diseases.
The renal biomarkers market size is anticipated to see significant growth, going up to $1.91 billion by 2029 at a compound annual growth rate (CAGR) of 8.5%. The projected growth can be ascribed to an array of factors such as streamlined integration of biomarker testing into routine clinical practice, personalized medicine, targeted therapies, and emerging markets in Asia and Latin America.
Don’t miss out on market insights. Grab your free sample now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=7711&type=smp
What’s Driving The Promising Growth Of The Renal Biomarkers Market?
The escalation in geriatric and pediatric renal patients is projected to drive the renal biomarkers market going forward. Geriatric renal patients refer to elderly patients aged above 70 years with advanced chronic kidney disease (CKD). Pediatric renal patients, on the other hand, are diagnosed with renal disorders during childhood and early adulthood. For example, according to the Australian Institute of Health and Welfare, chronic kidney disease (CKD) mortality rates surged by 4.2% in 2021 and 6.2% in 2022. Therefore, the rise in geriatric and pediatric renal patients is fostering the growth of the renal biomarkers market.
Which Are The Key Segments In The Renal Biomarkers Market?
The renal biomarkers market report categorizes the market into the following segments:
1) By Biomarker Type: Functional Biomarker, Up Regulated Protein, Other Biomarker Types
2) By Diagnostic Technique: Enzyme-Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay (PETIA), Colorimetric Assay, Chemiluminescent Enzyme Immunoassay (CLIA), Liquid Chromatography Mass Spectrometry (LS-MS)
3) By Application: Diagnosis And Disease Progression Monitoring, Research Homecare
4) By End User: Hospitals, Diagnostic Laboratories, Other End Users
Get instant delivery of your report, order now!
https://www.thebusinessresearchcompany.com/report/renal-biomarkers-global-market-report
Who Are The Major Players Of The Renal Biomarkers Market?
Major companies operating in the renal biomarkers market include Abbott Laboratories, BioPorto Diagnostics A/S, Roche Holding AG, Thermo Fisher Scientific, bioMérieux SA, Randox Laboratories, Siemens Healthineers, Beckman Coulter Inc., Astute Medical Inc., Nexelis Company, Sphingotec GmbH, Bio-Rad Laboratories India Pvt. Ltd., Enzo Biochem Inc., PerkinElmer Inc., Novartis AG, Alere Inc., AstraZeneca plc, Bio-Techne Corp., DiaSorin S.p.A., EKF Diagnostics Holdings plc, Fujirebio Diagnostics Inc., Gold Standard Diagnostics Corp., Merck KGaA, Myriad RBM Inc., Ortho Clinical Diagnostics Holdings plc, Quidel Corporation, R&D Systems Inc., Roche Diagnostics International Ltd., Sekisui Chemical Co. Ltd., Sysmex Corporation, Tosoh Bioscience Inc.
What Trends Are Influencing The Renal Biomarkers Market?
Major players in the renal biomarkers market are focused on creating innovative technologies to sustain their position in the market. Technological advancements are being recognized as a key trend influencing the market. For instance, in March 2022, Nipro Medical Corporation unveiled the cutting-edge SURDIAL DX. This state-of-the-art device integrates advanced technology for optimal patient safety, comfort, and efficiency.
Which Regions Are Leading And Fast-Growing In The Market?
North America was the largest region in the renal biomarkers market in 2024, while Asia-Pacific is expected to be the fastest-growing region during the forecast period. The regional analysis of the market spans across Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
What Does The Renal Biomarkers Market Report 2025 Offer?
Renal biomarkers are molecules such as proteins, lipids, genes, metabolites, or cells identified in a urinalysis used to evaluate the glomerular filtration rate of the kidney. An impairment in this rate signifies kidney damage. The renal biomarkers aid in predicting the nature and severity of kidney injury. The Renal Biomarkers Market research report from The Business Research Company presents global market size, growth rates, regional shares, competitor overview, detailed segments, trends, and opportunities.
Purchase the exclusive report now to unlock valuable market insights.
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7711
About The Business Research Company
The Business Research Company holds a robust reputation for providing comprehensive and data-rich research and insights comprising over 15000+ reports from 27 industries that cover 60+ geographies. You can get the information you need to stay ahead with the aid of our flagship product, the Global Market Model – a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
